Table 3.
Aspirin |
COX-2 selective NSAID |
||||||||
---|---|---|---|---|---|---|---|---|---|
No | Yes | Adjusted OR | 95% CI | No | Yes | Adjusted OR | 95% CI | ||
| |||||||||
Thoracic fractures | No | 1351(98.3%) | 646(98.8%) | 1.0 (Ref) | 1861(98.6%) | 134(97.1%) | 1.0 (Ref) | ||
Yes | 23(1.7%) | 8(1.2%) | 0.7 | 0.3,1.6 | 27(1.4%) | 4(2.9%) | 1.3 | 0.4,4.1 | |
Lumbar fracture | No | 1340(97.5%) | 628(96.0%) | 1.0 (Ref) | 1834(97.1%) | 132(95.7%) | 1.0 (Ref) | ||
Yes | 34(2.5%) | 26(4.0%) | 1.2 | 0.7,2.2 | 54(2.9%) | 6(3.4%) | 0.7 | 0.3,1.9 | |
Total spine fracture | No | 1321(96.1%) | 621(95.0%) | 1.0 (Ref) | 1812(96.0%) | 128(92.8%) | 1.0 (Ref) | ||
Yes | 53(3.9%) | 33(5.0%) | 1.1 | 0.6,1.7 | 76(4.0%) | 10(7.2%) | 1.1 | 0.5,2.2 |
Adjusted for age category, gender and traditional CVD risk factors, thyroid agents, oral steroids, anti-osteoporosis drug, vitamin D.